Skip to main content
Weight Loss
All Weight LossWeight Loss Health GuideMounjaroWegovyWegovy PillFoundayo
Sexual Performance
Erectile DysfunctionPremature EjaculationSildenafilViagra
Sexual Health
Bacterial VaginosisCystitisEmergency ContraceptionPeriod DelayThrush
STIs
ChlamydiaGenital HerpesGenital Warts
Pain Relief
ArthritisMigraineNumbing Cream
Hair, Skin and Nails
AcneCold SoresEczemaHair LossNail InfectionRosaceaVitamins
Allergies
Hay Fever
Digestive Health
Acid RefluxIBSThreadworm
Seasonal Viruses
COVID-19 TestsFlu
Travel Health
Anti-MalariaJet LagSleep
How it worksDeliveryFAQsReviewsAboutBlogAccount
GLP-1 Weight Loss Injections: Benefits, Comparisons and Side Effects - MedExpress
Featured

GLP-1 Weight Loss Injections: Benefits, Comparisons and Side Effects

Read our expert guide to help you learn more about GLP-1 weight loss injections, how they work and how they can help you reach your weight loss goals.

Reading time: 4 minutes

Weight loss treatment, clearly explained

From GLP-1 treatments like Wegovy and Mounjaro to side effects and realistic expectations, we break down what you need to know and how treatment can fit alongside healthier habits.

Semaglutide Tablets For Weight Loss

Semaglutide Tablets For Weight Loss: How They Work, Benefits And Side Effects

Considering semaglutide tablets for weight loss? Learn how they work, their side effects and why they may be the treatment of choice for some people.

Reading time: 10 minutes
What Is Fibremaxxing? The Fibre Trend Explained By Our Experts

What Is Fibremaxxing? The Fibre Trend Explained By Our Experts

Fibremaxxing is the latest health trend taking social media by storm. Our experts explain what it is, and how it can benefit your health.

Reading time: 6 minutes
Learn about Foundayo dosing

Foundayo Dosing: Which Strength Is Right For You?

Learn about Foundayo dosing, how orforglipron works and the important things to know about this new oral GLP-1 weight loss treatment.

Reading time: 6 minutes
Foundayo vs. Wegovy Pill

Foundayo vs Wegovy Pill: How the Two Oral GLP-1 Weight Loss Tablets Compare

Foundayo and the Wegovy pill are both once-daily weight loss tablets. Here's how they work, how they differ, and which one you can currently get in the UK.

Reading time: 7 minutes
Read more about Weight loss treatment, clearly explained

Erectile DysfunctionWeight LossMigrainePeriod Delay

FAQsDeliveryAbout usReferral schemeEducation discountAffiliate programmeComplaintsModern Slavery StatementBMI CalculatorMedExpress blogWeight Loss Health Guide

Treatments

Erectile DysfunctionWeight LossMigrainePeriod Delay

Information

FAQsDeliveryAbout usReferral schemeEducation discountAffiliate programmeComplaintsModern Slavery StatementBMI CalculatorMedExpress blogWeight Loss Health Guide

Have a question?

Help with a recent order

Track, manage, or get support with an order

Visit our help centre

Get instant answers


Terms of Sale

Terms

Privacy Policy

Regulation

Cookies

Price Match

Pharmacy Number 9012633

DMCA
© MedExpress Enterprises ltd 2026
Unit H, Ashbourne Drive, Leamington Spa, England, CV31 3SS
  • Company Number: 08805262
  • VAT Number: GB410090946
  • DUNS Number: 21-978-4663

Pharmacy Number 9012633

DMCA
Picture of a woman with a tape measure

Health Centre

Trusted insight and practical guidance for better health and wellbeing, backed by clinical expertise.

MedExpress

MedExpress Team

Weight LossSexual HealthHair Loss

Meet the team

Dr. Sophie Dix (BSc, PhD)

Dr. Sophie Dix (BSc, PhD)

Head of Medical Affairs

BSc Anatomical Science, University of Bristol MSc Neuroscience, University of Oxford PhD, Behavioural Neuroscience, Cardiff University

Dr. Sophie Dix is Head of Medical Affairs at MedExpress. A behavioural neuroscientist by training, Sophie has spent 30 years working at the intersection of medical research, pharmacology, technology and patient communication across the pharmaceutical industry, health technology and charity sectors. At MedExpress, Sophie's role is to ensure that everything the organisation does is grounded in the most current science. That means translating complex clinical evidence into accessible health information across the website, clinical pathways and media communications. It also means working with external press and broadcast media as a named expert commentator, making the science behind weight management and GLP-1 treatments understandable to a general audience. A core part of Sophie's work is building MedExpress's Real-World Evidence (RWE) programme: learning systematically from patient outcomes to understand what works in practice, not just in clinical trials. This patient-level insight feeds directly into improving patient experience and health outcomes. Sophie believes that patients make better decisions when they have access to accurate, evidence-based information. As an advocate for meaningful change in how obesity is understood, Sophie works to reduce stigma and raise awareness of the condition as an illness. This includes reframing the conversation around GLP-1s from aesthetics to public health, while highlighting the health benefits of weight loss and weight management.

Dr. Zoë Lees (PhD)

Dr. Zoë Lees (PhD)

Medical Writer

BSc (Hons), MSc, PhD

PhD Metabolic Medicine MSc Diabetes BSc (Hons) Biomedical Sciences Dr. Zoë Lees is a medical writer at MedExpress specialising in obesity and health communication. She completed her PhD at the University of Glasgow, where she investigated adipose tissue (fat tissue) function in pregnancies complicated by pre-eclampsia and gestational diabetes. Her work focuses on translating complex clinical evidence into clear, engaging and evidence-based health information for patients and the public. At MedExpress, Zoë contributes to clinical content, educational resources and media communications across areas including weight management, GLP-1 therapies and metabolic disease. Zoë is particularly interested in improving public understanding of obesity as a chronic condition and ensuring patients have access to accurate, accessible health information grounded in current scientific evidence.